ExCellThera announces publication in The Lancet Haematology highlighting excellent clinical results of ECT-001 in patients with haematological malignancies
November 06, 2019 07:00 ET
|
ExCellThera
MONTREAL, Nov. 06, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., an advanced biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use,...
BioCardia to Present at Dawson James Securities 5th Annual Small Cap Growth Conference
October 28, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program
October 23, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
BioCardia Receives CE Mark Renewal For Helix Biotherapeutic Delivery Catheter And Morph Guide Catheter Through May 2024
October 08, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
Dr. Frank Gerberick, Procter & Gamble Product Safety Veteran, Joins RenovaCare
September 24, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Sept. 24, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome
September 11, 2019 08:00 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements
September 05, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at...
Synchronicity Pharma Highlights New Research Demonstrating Beneficial Effects of Modulating Core Clock Proteins in Glioblastoma Stem Cells
August 27, 2019 09:00 ET
|
Synchronicity Pharma
SAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Synchronicity Pharma (“Synchronicity”), a clinical-stage company focused on therapeutic translation of circadian clock biology, today announced the...
BioCardia Reports 2019 Second Quarter Financial Results and Business Highlights
August 21, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
Dr. Robin Robinson, Founding Director of BARDA Joins RenovaCare
August 20, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Aug. 20, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...